Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.410
-0.280 (-10.41%)
At close: Jun 6, 2025, 4:00 PM
2.420
+0.010 (0.41%)
After-hours: Jun 6, 2025, 5:10 PM EDT
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $3.35 million as of June 6, 2025. Its market cap has decreased by -42.82% in one year.
Market Cap
3.35M
Enterprise Value
-11.48M
1-Year Change
-42.82%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $3.35M, a decrease of -36.59%. That is a compound annual growth rate of -9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 3.35M | -28.80% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.13B |
| Johnson & Johnson | 372.94B |
| AbbVie | 334.57B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.87B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |